TY - JOUR AU - Damber, J. E. AU - Aus, G. PY - 2008 DA - 2008// TI - Prostate cancer JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60729-1 DO - 10.1016/S0140-6736(08)60729-1 ID - Damber2008 ER - TY - JOUR AU - Logothetis, C. J. AU - Lin, S. H. PY - 2005 DA - 2005// TI - Osteoblasts in prostate cancer metastasis to bone JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1528 DO - 10.1038/nrc1528 ID - Logothetis2005 ER - TY - JOUR AU - Nørgaard, M. AU - Jensen, A. O. AU - Jacobsen, J. B. AU - Cetin, K. AU - Fryzek, J. P. AU - Sørensen, H. T. PY - 2010 DA - 2010// TI - Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007) JO - J Urol VL - 184 UR - https://doi.org/10.1016/j.juro.2010.03.034 DO - 10.1016/j.juro.2010.03.034 ID - Nørgaard2010 ER - TY - JOUR AU - Mohler, J. L. PY - 2010 DA - 2010// TI - The 2010 NCCN clinical practice guidelines in oncology on prostate cancer JO - J Natl Compr Canc Netw VL - 8 UR - https://doi.org/10.6004/jnccn.2010.0010 DO - 10.6004/jnccn.2010.0010 ID - Mohler2010 ER - TY - JOUR AU - Heidenreich, A. AU - Bellmunt, J. AU - Bolla, M. AU - Joniau, S. AU - Mason, M. AU - Matveev, V. PY - 2011 DA - 2011// TI - EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease JO - Eur Urol VL - 59 UR - https://doi.org/10.1016/j.eururo.2010.10.039 DO - 10.1016/j.eururo.2010.10.039 ID - Heidenreich2011 ER - TY - JOUR AU - Graham, J. AU - Kirkbride, P. AU - Cann, K. AU - Hasler, E. AU - Prettyjohns, M. PY - 2014 DA - 2014// TI - Prostate cancer: summary of updated NICE guidance JO - BMJ VL - 348 UR - https://doi.org/10.1136/bmj.f7524 DO - 10.1136/bmj.f7524 ID - Graham2014 ER - TY - JOUR AU - Bombardieri, E. AU - Aktolun, C. AU - Baum, R. P. AU - Bishof-Delaloye, A. AU - Buscombe, J. AU - Chatal, J. F. PY - 2003 DA - 2003// TI - Bone scintigraphy: procedure guidelines for tumour imaging JO - Eur J Nucl Med Mol Imaging VL - 30 ID - Bombardieri2003 ER - TY - JOUR AU - Zacho, H. D. AU - Barsi, T. AU - Mortensen, J. C. AU - Mogensen, M. K. AU - Bertelsen, H. AU - Josephsen, N. PY - 2014 DA - 2014// TI - Prospective multicenter study of bone scintigraphy in consecutive patients with newly diagnosed prostate cancer JO - Clin Nucl Med VL - 39 UR - https://doi.org/10.1097/RLU.0000000000000291 DO - 10.1097/RLU.0000000000000291 ID - Zacho2014 ER - TY - JOUR AU - Palmedo, H. AU - Marx, C. AU - Ebert, A. AU - Kreft, B. AU - Ko, Y. AU - Turler, A. PY - 2014 DA - 2014// TI - Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients JO - Eur J Nucl Med Mol Imaging VL - 41 UR - https://doi.org/10.1007/s00259-013-2532-6 DO - 10.1007/s00259-013-2532-6 ID - Palmedo2014 ER - TY - JOUR AU - Wondergem, M. AU - Zant, F. M. AU - Ploeg, T. AU - Knol, R. J. PY - 2013 DA - 2013// TI - A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer JO - Nucl Med Commun VL - 34 UR - https://doi.org/10.1097/MNM.0b013e328364918a DO - 10.1097/MNM.0b013e328364918a ID - Wondergem2013 ER - TY - JOUR AU - Wong, K. K. AU - Piert, M. PY - 2013 DA - 2013// TI - Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications JO - J Nucl Med VL - 54 UR - https://doi.org/10.2967/jnumed.112.114298 DO - 10.2967/jnumed.112.114298 ID - Wong2013 ER - TY - JOUR AU - Blake, G. M. AU - Park-Holohan, S. J. AU - Cook, G. J. AU - Fogelman, I. PY - 2001 DA - 2001// TI - Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate JO - Semin Nucl Med VL - 31 UR - https://doi.org/10.1053/snuc.2001.18742 DO - 10.1053/snuc.2001.18742 ID - Blake2001 ER - TY - JOUR AU - Even-Sapir, E. AU - Metser, U. AU - Mishani, E. AU - Lievshitz, G. AU - Lerman, H. AU - Leibovitch, I. PY - 2006 DA - 2006// TI - The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT JO - J Nucl Med VL - 47 ID - Even-Sapir2006 ER - TY - JOUR AU - Bossuyt, P. M. AU - Reitsma, J. B. AU - Bruns, D. E. AU - Gatsonis, C. A. AU - Glasziou, P. P. AU - Irwig, L. M. PY - 2004 DA - 2004// TI - Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative JO - Fam Pract VL - 21 UR - https://doi.org/10.1093/fampra/cmh103 DO - 10.1093/fampra/cmh103 ID - Bossuyt2004 ER - TY - JOUR AU - Schünemann, H. J. AU - Oxman, A. D. AU - Brozek, J. AU - Glasziou, P. AU - Jaeschke, R. AU - Vist, G. E. PY - 2008 DA - 2008// TI - Grading quality of evidence and strength of recommendations for diagnostic tests and strategies JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39500.677199.AE DO - 10.1136/bmj.39500.677199.AE ID - Schünemann2008 ER - TY - JOUR AU - Klotz, L. AU - Boccon-Gibod, L. AU - Shore, N. D. AU - Andreou, C. AU - Persson, B. E. AU - Cantor, P. PY - 2008 DA - 2008// TI - The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer JO - BJU Int VL - 102 UR - https://doi.org/10.1111/j.1464-410X.2008.08183.x DO - 10.1111/j.1464-410X.2008.08183.x ID - Klotz2008 ER - TY - JOUR AU - Nishiyama, T. PY - 2014 DA - 2014// TI - Serum testosterone levels after medical or surgical androgen deprivation: a comprehensive review of the literature JO - Urol Oncol VL - 32 UR - https://doi.org/10.1016/j.urolonc.2013.03.007 DO - 10.1016/j.urolonc.2013.03.007 ID - Nishiyama2014 ER - TY - JOUR AU - Labrie, F. AU - Dupont, A. AU - Belanger, A. AU - Giguere, M. AU - Lacoursiere, Y. AU - Emond, J. PY - 1985 DA - 1985// TI - Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival JO - J Steroid Biochem VL - 23 UR - https://doi.org/10.1016/S0022-4731(85)80024-8 DO - 10.1016/S0022-4731(85)80024-8 ID - Labrie1985 ER - TY - JOUR AU - Labrie, F. AU - Dupont, A. AU - Belanger, A. AU - Cusan, L. AU - Lacourciere, Y. AU - Monfette, G. PY - 1982 DA - 1982// TI - New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen JO - Clin Invest Med VL - 5 ID - Labrie1982 ER - TY - JOUR AU - Pollen, J. J. AU - Witztum, K. F. AU - Ashburn, W. L. PY - 1984 DA - 1984// TI - The flare phenomenon on radionuclide bone scan in metastatic prostate cancer JO - AJR Am J Roentgenol VL - 142 UR - https://doi.org/10.2214/ajr.142.4.773 DO - 10.2214/ajr.142.4.773 ID - Pollen1984 ER - TY - JOUR AU - Reza, M. AU - Bjartell, A. AU - Ohlsson, M. AU - Kaboteh, R. AU - Wollmer, P. AU - Edenbrandt, L. PY - 2014 DA - 2014// TI - Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy JO - EJNMMI Res. VL - 4 UR - https://doi.org/10.1186/s13550-014-0058-y DO - 10.1186/s13550-014-0058-y ID - Reza2014 ER - TY - JOUR AU - Johns, W. D. AU - Garnick, M. B. AU - Kaplan, W. D. PY - 1990 DA - 1990// TI - Leuprolide therapy for prostate cancer: An association with scintigraphic ''flare'' on bone scan JO - Clin Nucl Med. VL - 15 UR - https://doi.org/10.1097/00003072-199007000-00006 DO - 10.1097/00003072-199007000-00006 ID - Johns1990 ER - TY - JOUR AU - Messiou, C. PY - 2009 DA - 2009// TI - Cook G, deSouza NM: Imaging metastatic bone disease from carcinoma of the prostate JO - Br J Cancer. VL - 101 UR - https://doi.org/10.1038/sj.bjc.6605334 DO - 10.1038/sj.bjc.6605334 ID - Messiou2009 ER - TY - JOUR AU - Scher, H. I. PY - 2003 DA - 2003// TI - Prostate carcinoma: defining therapeutic objectives and improving overall outcomes JO - Cancer. VL - 97 UR - https://doi.org/10.1002/cncr.11151 DO - 10.1002/cncr.11151 ID - Scher2003 ER - TY - JOUR AU - Brown, M. S. AU - Chu, G. H. PY - 2012 DA - 2012// TI - Kim HJ, len-Auerbach M, Poon C JO - Bridges J et al. Computer-aided quantitative bone scan assessment of prostate cancer treatment response. Nucl Med Commun. VL - 33 ID - Brown2012 ER - TY - JOUR AU - Heidenreich, A. AU - Bastian, P. J. AU - Bellmunt, J. AU - Bolla, M. AU - Joniau, S. PY - 2014 DA - 2014// TI - van der KT et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer JO - Eur Urol VL - 65 UR - https://doi.org/10.1016/j.eururo.2013.11.002 DO - 10.1016/j.eururo.2013.11.002 ID - Heidenreich2014 ER - TY - JOUR AU - Donohoe, K. J. AU - Brown, M. L. AU - Collier, B. D. PY - 2003 DA - 2003// TI - Society of nuclear medicine procedure guideline for bone scintigraphy JO - Bone Scintigraphy. VL - 205 ID - Donohoe2003 ER - TY - JOUR AU - Hellwig, D. AU - Krause, B. J. AU - Schirrmeister, H. AU - Freesmeyer, M. PY - 2010 DA - 2010// TI - Bone scanning with sodium 18F-fluoride PET and PET/CT. German guideline Version 1.0. JO - Nuklearmedizin VL - 49 UR - https://doi.org/10.3413/nukmed-0343 DO - 10.3413/nukmed-0343 ID - Hellwig2010 ER - TY - STD TI - Segall G, Delbeke D, Stabin MG, Even-Sapir E, Fair J, Sajdak R et al. SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med. 2010; 51:1813-1820. ID - ref29 ER - TY - JOUR AU - Schuetz, G. M. AU - Schlattmann, P. AU - Dewey, M. PY - 2012 DA - 2012// TI - Use of 3x2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests: meta-analytical evaluation of coronary CT angiography studies JO - BMJ. VL - 345 UR - https://doi.org/10.1136/bmj.e6717 DO - 10.1136/bmj.e6717 ID - Schuetz2012 ER - TY - JOUR AU - Hayen, A. AU - Macaskill, P. AU - Irwig, L. AU - Bossuyt, P. PY - 2010 DA - 2010// TI - Appropriate statistical methods are required to assess diagnostic tests for replacement, add-on, and triage JO - J Clin Epidemiol. VL - 63 UR - https://doi.org/10.1016/j.jclinepi.2009.08.024 DO - 10.1016/j.jclinepi.2009.08.024 ID - Hayen2010 ER - TY - JOUR AU - Brozek, J. L. AU - Akl, E. A. AU - Jaeschke, R. AU - Lang, D. M. AU - Bossuyt, P. AU - Glasziou, P. PY - 2009 DA - 2009// TI - Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies JO - Allergy VL - 64 UR - https://doi.org/10.1111/j.1398-9995.2009.02083.x DO - 10.1111/j.1398-9995.2009.02083.x ID - Brozek2009 ER - TY - JOUR AU - Donohoe, K. J. AU - Brown, M. L. AU - Collier, B. D. PY - 2003 DA - 2003// TI - Society of nuclear medicine procedure guideline for bone scintigraphy JO - Bone Scintigraphy. VL - 205 ID - Donohoe2003 ER - TY - STD TI - Lecouvet FE, Talbot JN, Messiou C, Bourguet P, Liu Y, de Souza NM: Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group. Eur J Cancer. 2014. ID - ref34 ER - TY - STD TI - Poonacha TK, Go RS: Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol. 2011;29:186-91. ID - ref35 ER - TY - JOUR AU - Iagaru, A. AU - Mittra, E. AU - Dick, D. W. AU - Gambhir, S. S. PY - 2012 DA - 2012// TI - Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases JO - Mol Imaging Biol. VL - 14 UR - https://doi.org/10.1007/s11307-011-0486-2 DO - 10.1007/s11307-011-0486-2 ID - Iagaru2012 ER - TY - JOUR AU - Damle, N. A. AU - Bal, C. AU - Bandopadhyaya, G. P. AU - Kumar, L. AU - Kumar, P. AU - Malhotra, A. PY - 2013 DA - 2013// TI - The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan JO - Jpn J Radiol. VL - 31 UR - https://doi.org/10.1007/s11604-013-0179-7 DO - 10.1007/s11604-013-0179-7 ID - Damle2013 ER - TY - STD TI - Withofs N, Grayet B, Tancredi T, Rorive A, Mella C, Giacomelli F et al.: (1)(8)F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nucl Med Commun. 2011;32:168-76. ID - ref38 ER - TY - STD TI - National Comprehensive Cancer Network. Prostate Cancer (Version 2.2014). 2014. 6. Ref Type: Internet Communication. ID - ref39 ER -